Yvonne Wesseling-Rozendaal

7PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Tumour immunologyMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 21, 2024
Increased PI3K pathway activity is associated with recurrent breast cancer in patients with low and intermediate 21-gene recurrence score.

Lawrence Hsu Lin, Yvonne Wesseling-Rozendaal, Varshini Vasudevaraja

|Jun 26, 2023
Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors.

Naoual Menssouri, Loïc Poiraudeau, Carole Helissey

|Nov 26, 2022
A Systems Analysis of Phenotype Heterogeneity in APOE*3Leiden.CETP Mice Induced by Long-Term High-Fat High-Cholesterol Diet Feeding.

Yared Paalvast, Enchen Zhou, Yvonne J W Rozendaal

|Feb 15, 2022
Characterization of Immunoactive and Immunotolerant CD4+ T Cells in Breast Cancer by Measuring Activity of Signaling Pathways That Determine Immune Cell Function.

Yvonne Wesseling-Rozendaal, Arie van Doorn, Karen Willard-Gallo

|Oct 23, 2021
Survival Is Related to Estrogen Signal Transduction Pathway Activity in Postmenopausal Women Diagnosed with High-Grade Serous Ovarian Carcinoma.

Laura van Lieshout, Phyllis van der Ploeg, Yvonne Wesseling-Rozendaal

|Feb 28, 2019
Computational modelling of energy balance in individuals with Metabolic Syndrome.

Yvonne J W Rozendaal, Yanan Wang, Peter A J Hilbers

Pageof 2

Frequent Collaborators

2 joint publications

Ko Willems van Dijk

2 joint publications

Patrick C N Rensen

2 joint publications

Natal A W van Riel

2 joint publications

Anja van de Stolpe